Clinical Trials for Lymphoma, Non-Hodgkin

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

NCT ID: NCT06788509

A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant

NCT ID: NCT05540340

This clinical trial is studying a new method to calculate the dose of a chemotherapy drug called melphalan for patients with lymphoma who are preparing for a specific type of treatment known as an ...

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

NCT ID: NCT02682667

This clinical trial is focused on understanding different types of cancer, including multiple myeloma, lymphoma, and non-small cell lung cancer. Researchers aim to collect and study tissue and bloo...

A Study of JNJ-87801493 in Combination With T-Cell Engagers in Participants With B-cell Non-Hodgkin Lymphoid (NHLs) Cancer

NCT ID: NCT06139406

This clinical trial is studying a new treatment called JNJ-87801493, which is being tested in combination with another type of therapy known as T-cell engagers. The goal is to find out if this comb...

A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)

NCT ID: NCT04245839

This clinical trial is testing a new treatment called JCAR017 for adults with specific types of Non-Hodgkin Lymphoma (NHL), particularly those whose lymphoma has come back or hasn’t responded to pr...

Tissue Collection for Studies of Lymph Cancer

NCT ID: NCT01676805

This clinical trial is focused on collecting tissue samples from patients with various types of lymph-related cancers, such as Hodgkin disease, non-Hodgkin lymphoma, and multiple myeloma. The goal ...

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

NCT ID: NCT02693535

The TAPUR trial is studying how effective certain FDA-approved drugs are for patients with advanced cancers, such as lymphoma, multiple myeloma, and solid tumors, that have specific genetic changes...

A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

NCT ID: NCT04077723

This clinical trial is looking at a new treatment for patients with relapsed or refractory B-Cell Non-Hodgkin's Lymphoma, a type of cancer that affects the lymphatic system. The study is testing a ...

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

NCT ID: NCT05800210

This clinical trial is investigating a new treatment approach for patients with certain types of blood cancers, including acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and vario...

A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers

NCT ID: NCT06120504

This clinical trial is investigating a new drug called SGN-35T for adults with advanced forms of lymphoma, a type of cancer that affects the blood cells responsible for fighting infections. The tri...

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies

NCT ID: NCT05442515

This clinical trial is studying a new treatment for children and young adults with certain types of leukemia and lymphoma that have not responded to standard treatments. It uses a special therapy c...

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma

NCT ID: NCT05255601

This clinical trial is exploring a new treatment combination called relatlimab and nivolumab for children and young adults with certain types of lymphoma, specifically classical Hodgkin lymphoma an...

A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies

NCT ID: NCT06045910

This clinical trial is studying a new treatment called ALETA-001 for patients with certain types of B-cell cancers, including different forms of lymphoma. Specifically, it is looking at how safe an...

A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma

NCT ID: NCT05421663

This clinical trial is investigating a new treatment called JNJ-90014496 for adults with a type of blood cancer known as relapsed or refractory B-Cell Non-Hodgkin Lymphoma. This therapy uses modifi...

A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

NCT ID: NCT06470438

This clinical trial is studying a new treatment called JNJ-88998377 for patients with relapsed or refractory B-cell Non-Hodgkin's Lymphoma, which means their cancer has come back or hasn’t responde...

A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL)

NCT ID: NCT06660563

This clinical trial is studying a new treatment called JNJ-80948543, which is being tested in combination with another drug, JNJ-75348780, for patients with a type of cancer known as relapsed or re...

Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III

NCT ID: NCT03117036

The Samsung Lymphoma Cohort Study III is a research trial aimed at understanding how patients with aggressive forms of lymphoma, including both Hodgkin and non-Hodgkin lymphomas, respond to treatme...

Long-Term Follow-up Study

NCT ID: NCT05332054

A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

NCT ID: NCT05424822

This clinical trial is studying a new treatment called JNJ-80948543, which is an experimental antibody designed to help the immune system target specific types of blood cancers, including non-Hodgk...

Evaluation of Lymphoma Prognosis and Survivorship in Recently Diagnosed Patients, LEO Study

NCT ID: NCT04996706